SCHEMBL8779280

SCHEMBL8779280

Cc1ccc(-c2nc(C)c3c(C)cccc3n2)nc1-c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 4/20 0.42
LMNA P02545 3/20 0.42
HPGD P15428 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
ALDH1A1 P00352 3/20 0.39
POLB P06746 3/20 0.39
KDM4E B2RXH2 2/20 0.39
MAPT P10636 2/20 0.39
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
RAB9A P51151 2/20 0.39
PKM P14618 1/20 0.39
TDP1 Q9NUW8 1/20 0.37
DHODH Q02127 2/20 0.36
ATM Q13315 1/20 0.35
GLA P06280 1/20 0.35
PIK3CD O00329 1/20 0.35
PIK3CG P48736 1/20 0.35
NR1I3 Q14994 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28054676 0.85 LMNA (0.52) PDE10ALMNAHPGDSMN1; SMN2ALDH1A1
SCHEMBL3787452 0.84 PDE10A (0.54) PDE10ALMNAHPGDSMN1; SMN2ALDH1A1
SCHEMBL8779217 0.78 PARP1 (0.42) PDE10ALMNAHPGDSMN1; SMN2ALDH1A1
SCHEMBL3795393 0.78 PDE10A (0.42) PDE10ALMNAHPGDSMN1; SMN2ALDH1A1
SCHEMBL18698079 0.77 HPGD (0.51) PDE10ALMNAHPGDSMN1; SMN2ALDH1A1
SCHEMBL8814851 0.76 TGFBR1 (0.45) PDE10ALMNAHPGDSMN1; SMN2TDP1
SCHEMBL10697834 0.76 L3MBTL1 (0.57) PDE10ALMNAHPGDSMN1; SMN2ALDH1A1
SCHEMBL12318278 0.75 DHODH (0.45) PDE10ASMN1; SMN2POLBDHODHATM
SCHEMBL8776938 0.74 PDE10A (0.51) PDE10ALMNASMN1; SMN2ALDH1A1POLB
SCHEMBL9607686 0.74 POLB (0.43) PDE10ALMNAHPGDSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012069652-A2 FUNGICIDE MIXTURES SYNGENTA PARTICIPATIONS AG (CH) 2012-05-31 WO disclosed
US-20120129875-A1 SUBSTITUTED QUINAZOLINES AS FUNGICIDES SYNGENTA CROP PROTECTION, LLC (US) 2012-05-24 US disclosed
US-20120129875-A1 SUBSTITUTED QUINAZOLINES AS FUNGICIDES SYNGENTA CROP PROTECTION, LLC (US) 2012-05-24 US disclosed
WO-2010136475-A1 SUBSTITUTED QUINAZOLINES AS FUNGICIDES SYNGENTA PARTICIPATIONS AG (CH) 2010-12-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120129875-A1 SUBSTITUTED QUINAZOLINES AS FUNGICIDES NAT1, NQO2, NOX1 PDE10A 1335/4885LMNA 3612/4885HPGD 1679/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.